Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-01-04
2005-01-04
Chang, Ceila (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S238000, C546S146000, C514S252040, C514S307000
Reexamination Certificate
active
06838465
ABSTRACT:
This invention relates to novel compounds represented by the general formula [I]:(wherein, R1and R4are the same or different, and represent hydrogen atoms, lower alkyl groups or the like; R2and R3are the same or different, and represent lower alkoxy groups or lower alkyl groups; R5represents a lower alkyl group or aralkyl group optionally having substituent(s); R6represents a hydrogen atom or a lower alkyl group; X represents O, S or NH; m represents an integer of 0 to 3; n represents an integer of 0 or 1; and Ar represents a phenyl group or heteroaryl group optionally having substituent(s)).The compounds of the invention have an antagonistic action on orexin receptors, and are useful for treatment of appetite abnormality, obesity, sleeping disorder or the like.
REFERENCES:
patent: 0675112 (1995-04-01), None
patent: 0 675 112 (1995-10-01), None
patent: WO 9212132 (1992-07-01), None
patent: WO 9639384 (1996-12-01), None
patent: WO-9639384 (1996-12-01), None
patent: WO 9909024 (1999-02-01), None
patent: 9923078 (1999-05-01), None
patent: WO 9958533 (1999-11-01), None
Accession No. 2001:904039 CHEMCATS listing of ComGenex Product List, RN 336858-32-3, published in 2001.*
Answer 1 of 15 Registry Copyright 2002 ACS, RN 292028-76-3 Registry, “Ring System Data”.
Hirose Masaaki
Iwaasa Hisashi
Yamada Koji
Banyu Pharmaceutical Co. Ltd.
Chang Ceila
Coppins Janet L
Nixon & Vanderhye P.C.
LandOfFree
N-acyltetrahydroisoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-acyltetrahydroisoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-acyltetrahydroisoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3436578